Oxycodone Market size is valued at $5.1 billion in 2020 and is expected to grow with a CAGR of 4.3% during the forecast period 2021-2026. Oxycodone is an opioid that is used to help in relieve moderate to severe pain. It belongs to class of known as opioid analgesics which helps in pain management. It works in the brain to adjust the way the body feels and reacts to pain. It is generally present in table, capsule or liquid form. It can be used short term or long term but overdose of oxycodone leads to de-addiction. There are two types of oxycodone based on their activity such as short acting oxycodone and long activity oxycodone. Increasing prevalence of orthopedic disorders, such as rheumatoid arthritis, elbow pain, fibromyalgia, and osteoporosis which associated with chronic pain is major factor driving the growth of the market. Moreover, growing demand for oxycodone to relieve post-surgery pain further enhance the overall market demand for Oxycodone during the aforesaid period.

Oxycodone Market Segment Analysis- By Route of Administration

Based on the route of administration, Oxycodone Market is segmented into oral, parenteral. The parenteral segment is estimated to dominate the market during the period 2021-2026. This is attributed due to more effective and safe usage in the treatment of cancer and other disease for pain management. Furthermore, various types of drugs are available in different dosages in the parenteral form. The oral, segment is forecast to be the fastest-growing segment and is projected to grow at a CAGR of 4.1% during the period 2021-2026. This is mainly owing to many individuals opting for oral administration of drugs compared to injection of drugs.

Request for Sample Report @ https://www.industryarc.com/pdfdownload.php?id=508310

Report Price: $ 5900 (Single User License)

Oxycodone Market Segment Analysis- By Application

Based on the application, Oxycodone Market is segmented into cancer pain management, Neuropathic pain management, Osteoarthritis pain management, other pain management. In 2020, Osteoarthritis pain management is estimated to hold major share in the market. This is mainly rising prevalence of orthopedic disorder such as elbow pain, fibromyalgia, rheumatoid arthritis, and chronic pain which leads to rise in demand for pain relievers. Moreover, According to, Center for Disease Control and Prevention (CDC), in U.S. around 30 million patients are affected by osteoarthritis each year also contributing to the dominance of this segment. Also, cancer pain management is projected to grow with a CAGR of 3.9% over the period 2021-2026. This is owing to rising adoption of oxycodone relieve post-surgery pain of cancer.

Oxycodone Market Segment Analysis- By Geography

North America dominated the Oxycodone market share accounting for 41% of the market in 2020. This is mainly owing to increasing prevalence of chronic diseases such as heart diseases, diabetes, obesity and others among geriatric population which leads to rise in demand for oxycodnein this region. According to, Centres for Disease Control and Prevention (CDC), chronic diseases such as heart disease, cancer, and diabetes are the leading causes of death and disability in the United States. However, the Asia-Pacific region is projected to be the fastest-growing over the period 2021-2026. This is owing to rising expenditure on healthcare coupled with rising advancement in drug market.

Oxycodone Market Drivers

Increasing Prevalence of Orthopedic Disorders

Increasing prevalence of orthopedic disorders, such as rheumatoid arthritis, elbow pain, fibromyalgia, and osteoporosis, chronic pain across the globe is driving the growth of Oxycodone market. According to, the International Osteoporosis Foundation, osteoporosis is the one of the most serious public health concern among women, around 30% of the people affected each year in U.S. and Europe. Moreover, increasing incidence of medical ailment and high surge in post-operative pain is also set to increase the market growth.

Rising Technological Advancement

Increase in research and development of advanced technology for Oxycodone is also driving the market. New product development and innovation in formulations and drug designing such as abuse-deterrent formulations done in Oxycontin and Opana. Also, advanced drug formulations such as extended-release medications for pain control are examples of improved formulation is also set to the growth of Oxycodone Market.

Download Sample Report @ https://www.industryarc.com/pdfdownload.php?id=508310

Oxycodone Market Challenges

Side effect of oxycodone cause vomiting, bladder pain, abdominal cramps, diarrhea, breathing problem, bone/joint pain and constipation and also overdose of oxycodone leads to de-addiction is challenging the market. Along with this certain severe cases of adverse reaction the patient mat suffer psychological problem such as depression are also further challenging the growth of the market.

COVID-19 Impact

Moreover, the outbreak of COVID-19 around the world has impacted all industries including healthcare industry. Covid- 19 affects the Oxycodone market including drastic reduction demand owing to lack of visits to healthcare facilities such as hospitals and clinics. Also owing to widespread of coronavirus it affects workforce and staffing issues, procedural prioritisation. These affects Oxycodone market by cancellation of scheduled visit for primary care at hospitals and reflecting patients concern about infection.

Oxycodone Market Landscape

Product launches, Merger & Acquisitions, Joint Ventures and R&D activities are key strategies adopted by players in the Oxycodone Market. Oxycodone top 10 companies are Sanofi-Aventis S.A., Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals USA, Inc., Janssen Pharmaceuticals Inc., Teikoku Pharma USA Inc., Mylan NV, Acorda Therapeutics, Daiichi Sankyo and Endo Pharmaceuticals.

Acquisitions/Product Launches

In September 2019, Daiichi Sankyo Company Limited launched new generic formulation of oxycodone hydrochloride hydrate extended release tablets for sustained cancer pain treatment in Japan.

Key Takeaways

In 2020, North America dominated the Oxycodone Market owing to rising incidence of chronic diseases.

Increasing innovation and development in oxycodone across the globe is driving the market growth of Oxycodone.

Detailed analysis of the Strength, Weakness, and opportunities of the prominent players operating in the market will be provided in the Oxycodone Market report.

Side effects of oxycodone causes breathing problems and allergic reactions such as rash, itching, hives, and swelling on face, lips, or tong are challenging the growth of the market.

Related Reports :

A. Analgesics Market

https://www.industryarc.com/Report/15399/analgesics-market.html

B. Antiviral Drug Market

https://www.industryarc.com/Report/19279/antiviral-drugs-market.html

For more Lifesciences and Healthcare Market reports, please click here

About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to [email protected] to discuss more about our consulting services.

Tags: Oxycodone Market, Oxycodone Market Share, Oxycodone Market Size, Oxycodone Market Forecast, Oxycodone Market research, Oxycodone Market growth, Oxycodone market trends, Oxycodone Market Outlook, Oxycodone Market analysis, Oxycodone market revenue

See Campaign: https://www.industryarc.com/reports/request-quote?id=508310
Contact Information:
Venkat Reddy Sales Director Email: [email protected] Website: https://www.industryarc.com Phone: (+1) 970-236-3677

Tags:
Menafn, Reportedtimes, PR-Wirein, iCN Internal Distribution, Extended Distribution, Research Newswire, English